Co-occurrence of neurodevelopmental genes in etiopathogenesis of autism and schizophrenia

Schizophrenia Research

Volumn 118, Issue 1-3, 2010, Pages 303-304

  Fatemi, S Hossein ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3',5' CYCLIC ADENOSINE MONOPHOSPHATE; ADENOSINE PHOSPHATE; DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DECARBOXYLASE; PHOSPHODIESTERASE IV; REELIN; UNCLASSIFIED DRUG;

AUTISM; BIPOLAR DISORDER; BRAIN FUNCTION; DOPAMINE RELEASE; GABAERGIC TRANSMISSION; GENE EXPRESSION; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

AUTISTIC DISORDER; CELL ADHESION MOLECULES, NEURONAL; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; EXTRACELLULAR MATRIX PROTEINS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DECARBOXYLASE; HUMANS; NERVE TISSUE PROTEINS; SCHIZOPHRENIA; SERINE ENDOPEPTIDASES;

EID: 77951962610     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.01.018     Document Type: Letter

References (10)

1. Braun N.N., Reutiman T.J., Lee S., Folsom T.D., Fatemi S.H. Expression of phosphodiesterase 4 is altered in brain of subjects with autism. NeuroReport 2007, 18(17):1841-1844.
2. Bullock W.M., Cardon K., Bustillo J., Roberts R.C., Perrone-Bizzozero N.I. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients. Am. J. Psychiatry 2008, 165(12):1594-1603.
3. Fatemi S.H. Reelin glycoprotein: structure, biology and role in health and disease. Mol. Psychiatry 2005, 10(3):251-257.
4. Fatemi S.H., Halt A.R., Stary J.M., Kanodia R., Schulz S.C., Realmuto G.R. Glutamic acid decarboxylase 65 and 67kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 2002, 52(8):805-810.
5. Fatemi S.H., King D.P., Reutiman T.J., Folsom T.D., Laurence J.A., Lee S., Fan Y.T., Paciga S.A., Conti M., Menniti F.S. PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia. Schizophr. Res. 2008, 101(1-3):36-49.
6. Fatemi, S.H., Reutiman, T.J., Folsom, T.D., Rooney, R.J., Patel, O.H., Thuras, P.D., in press. mRNA and protein levels for GABAAα4, α5, β1 and GABABR1 receptors are altered in brains from subjects with autism. J. Aut. Dev. Disord. doi:10.1007/s10803-009-0924-z.
7. Guidotti A., Auta J., Davis J.M., DizGiorgi-Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., Costa E., DiGiorgi Gerevini V. Decrease in reelin and glutamic acid decarboxylase 67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 2000, 57(11):1061-1069.
8. Laurence J.A., Fatemi S.H. Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum 2005, 4(3):206-210.
9. Oblak A., Gibbs T.T., Blatt G.J. Decreased GABAA receptors in benzodiazepine binding sites in the anterior cingulated cortex in autism. Autism Res. 2009, 2(4):205-219.
10. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005, 57(1):67-81.